Log In
Print
BCIQ
Print
Print this Print this
 

Capesaris (GTx-758)

  Manage Alerts
Collapse Summary General Information
Company GTx Inc.
DescriptionOral selective estrogen receptor alpha agonist
Molecular Target Estrogen receptor alpha
Mechanism of ActionEstrogen receptor alpha agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationProstate cancer
Indication DetailsTreat advanced prostate cancer; Treat metastatic castration-resistant prostate cancer (CRPC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today